Organigram Holdings (TSX: OGI) (NASDAQ: OGI) has performed what amounts to a management shuffle between its board of directors and executive leadership team. The firms current chief financial officer, Paolo De Luca, has been moved to the role of chief strategy officer, while a board member takes up the role of CFO for the firm.
De Luca had served within the role of CFO at Organigram since that of December 2017, and was responsible for raising over a quarter of a billion dollars for the firm as well as uplisting to both the Toronto Stock Exchange and the NASDAQ. Moving to the role of chief strategy officer, De Luca will now be responsible for establishing and reviewing key strategic priorities from the firm and will report directly to the CEO. Both investor relations and corporate development will continue to report to him.
Taking De Luca’s role as CFO will be that of Derrick West, whom has maintained a role on the company’s board of directors since December 2017. Previously, he was the chief financial officer of Partners REIT from 2014 until December 2019. Holding the CPA designation, he’s an alumni of Mount Allison University. In connection with his appointment to the executive leadership team, West will be resigning from the board of directors of Organigram.
Organigram Holdings last traded at $2.13 on the Nasdaq.
Information for this briefing was found via Sedar and Organigram Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.